GTR Test Accession:
Help
GTR000508381.5
CAP
Last updated in GTR:
2021-10-07
View version history
GTR000508381.5,
last updated:
2021-10-07
GTR000508381.4,
last updated:
2020-10-22
GTR000508381.3,
last updated:
2018-10-11
GTR000508381.2,
last updated:
2016-03-09
GTR000508381.1,
registered in GTR:
2014-01-10
Last annual review date for the lab: 2024-10-09
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Monitoring;
Predictive; ...
Conditions (25):
Help
Chromosomal gains, losses, deletions, translocations, and markers
Methods (1):
Help
Cytogenetics - Karyotyping: G-banding
Target population: Help
Not provided
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Test short name:
Help
Chromosomes
Specimen Source:
Help
- Bone marrow
- Cancer blood, solid tumor, lymphatic tissue/node
- View specimen requirements
Who can order: Help
- Health Care Provider
- Licensed Physician
- Nurse Practitioner
How to Order:
Help
Send 3-4 ml bone marrow in a 4 ml sodium heparin tube at room temperature. Bone marrow from 1st or 2nd aspirate using a sodium-heparinized syringe is needed. We can provide you a complimentary test kit with the requisition upon request. The requisition is found at www.reglab.org, select client services …
Order URL
Informed consent required:
Help
No
Pre-test genetic counseling required:
Help
No
Post-test genetic counseling required:
Help
No
Recommended fields not provided:
Test Order Code,
Lab contact for this test,
Contact policy,
Test strategy,
Test development
Conditions
Help
Total conditions: 25
| Condition/Phenotype | Identifier |
|---|
Test Targets
Chromosomal regions/Mitochondria
Help
Total chromosomal regions/mitochondria: 1
| Chromosomal region/Mitochondrion | Associated condition |
|---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument
Karyotyping
G-banding
Other
Clinical Information
Test purpose:
Help
Diagnosis;
Monitoring;
Predictive;
Prognostic;
Recurrence;
Risk Assessment;
Screening;
Therapeutic management
Recommended fields not provided:
Clinical validity,
Clinical utility,
Target population,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
This test is used for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendment of 1998 ("CLIA") as qualified to perform high complexity clinical testing.
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Not provided
Additional Information
Reviews:
Clinical resources:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.